Genetic-based animal biotechnology has produced new food and pharmaceutical products and promises many more advances to benefit humankind. These exciting prospects are accompanied by considerable unease, however, about matters such as safety and ethics. This book identifies science-based and policy-related concerns about animal biotechnologyâ€"key issues that must be resolved before the new breakthroughs can reach their potential. The book includes a short history of the field and provides understandable definitions of terms like cloning. Looking at technologies on the near horizon, the authors discuss what we know and what we fear about their effectsâ€"the inadvertent release of dangerous microorganisms, the safety of products derived from biotechnology, the impact of genetically engineered animals on their environment. In addition to these concerns, the book explores animal welfare concerns, and our societal and institutional capacity to manage and regulate the technology and its products. This accessible volume will be important to everyone interested in the implications of the use of animal biotechnology.

The genetic improvement of fish for aquaculture and related fisheries has seen huge advances over recent years. Building upon the previous two editions of Aquaculture and Fisheries Biotechnology: Genetic Approaches, this 3rd edition offers a presentation of traditional selective breeding, modern genetic biotechnology, genomics, gene transfer and gene editing, and the latest developments in genetic biotechnology such as epigenetics, xenogenesis and genome-wide association study coupled with commercial application, the impact of government regulation and expectations for the future. It provides a firm grounding in relevant aspects of classical genetics, before focusing on particular aspects such as sex reversal and breeding as applied in aquaculture and fisheries. It also explores how more recent molecular genetics, genomics and biotechnology techniques can be used and combined in improvement programmes for fish and aquaculture species. A glossary explains the latest terminology used in biotechnology and genetics. This book will be useful for research scientists and students in marine biotechnology, aquaculture biotechnology, and fish genetics and breeding.

This updated text explains how advances in mammalian and plant genetics contribute to better therapeutics agents and more wholesome foods. It addresses such topics as new pharmaceutical agents, agribiotechnology, safety evaluation of biotechnology-derived drugs, food safety, nutritional science, and regulatory and environmental aspects of genetically-modified organisms. New to this edition are chapters on biotherapeutics and herbicide-resistant crops. It should be of interest to biotechnology, toxicologists, pharmaceutical scientists, environmental scientists and agriculturists.

Talk of genetically engineered organisms (GEOs) has moved from the hushed corridors of life science corporations to the front pages of major newspapers. This book examines these issues from the diverse perspectives of sociology, geography, law environmental studies and political science.

In this book, numerous prominent aquaculture researchers contribute 27 chapters that provide overviews of aquaculture effects on the environment. They comprise a comprehensive synthesis of many ecological and genetic problems implicated in the practice of aquaculture and of many proven, attempted, or postulated solutions to those problems. This is an outstanding source of reference for all types of aquaculture activities.

Within the context of the Convention on Biological Diversity (CBD), the Cartagena Protocol on Biosafety (CPB) was established as an implementing agreement. The CPB is an international agreement establishing the rights of recipient countries to be notified of and to approve or reject the domestic import and/or production of living modified organisms (LMOs). Decisions regarding import/production are to be on the basis of a biosafety assessment. Article 26.1 of the CPB allows for the (optional) inclusion of socio-economic considerations (SECs) into that biosafety assessment process. This book compiles expert assessments of the issues relevant to SEC assessment of LMOs and fundamental for decisions regarding whether to undertake such assessments at all. It includes an overview of the inclusion of SEC assessment in the regulation of LMOs that looks at the rationale for the inclusion of SECs, in the context of the existing science-based risk assessment systems. This book reviews the various factors that can and have been suggested for inclusion in SEC assessment, and provides a meaningful dialogue about the contrasts, benefits and tradeoffs that are, and will, be created by the potential move to the inclusion of SECs in the regulation of LMOs, making it of interest to both academics and policy-makers.

Genetically engineered organisms (GEOs) have been under development for more than 20 years while GE crops have been grown commercially during the last decade. During this time, a number of questions have cropped up concerning the potential consequences that certain GEOs might have on natural or managed ecosystems and human health. Interest in developing methods to confine some GEOs and their transgenes to specifically designated release settings has increased and the success of these efforts could facilitate the continued growth and development of this technology. Biological Confinement of Genetically Engineered Organisms examines biological methods that may be used with genetically engineered plants, animals, microbes, and fungi. Bioconfinement methods have been applied successfully to a few non-engineered organisms, but many promising techniques remain in the conceptual and experimental stages of development. This book reviews and evaluates these methods, discusses when and why to consider their use, and assesses how effectively they offer a significant reduction of the risks engineered organisms can present to the environment. Interdisciplinary research to develop new confinement methods could find ways to minimize the potential for unintended effects on human health and the environment. Need for this type of research is clear and successful methods could prove helpful in promoting regulatory approval for commercialization of future genetically engineered organisms.